The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

KwaZulu-Natal Health Department reports significant stabilisation in medicine availability, while grappling with critical ...

The Department of Health in KwaZulu-Natal has blamed a shortage of insulin on the global Ozempic frenzy. The medication, ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

Last Wednesday was the final day for bills to make it out of their house of origin in the Washington State legislature. While ...

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

Insulin has become the focal point of the medicine ... The company said its products will cost no more than $30 per vial or $55 for five pen cartridges, adding that compares to around $329 per ...

The reason a price cap is being targeted is due to the rapid increase in the cost of insulin products over the last few decades. According to research, one vial of Humalog (insulin lispro ...

The Oklahoma Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management. Called GLP-1 agonists and used ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...